![Plants in Leverkusen will be operated by WuXi Biologics and will serve as a back-up site for final product manufacturing of Kovaltry™](https://news.europawire.eu/wp-content/uploads/2020/01/Plants-in-Leverkusen-will-be-operated-by-WuXi-Biologics-and-will-serve-as-a-back-up-site-for-final-product-manufacturing-of-Kovaltry™-144x144.jpg)
(PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 — /EuropaWire/ — Life science, health care and nutrition global enterprise Bayer announced that the leading global open-access biologics technology firm WuXi Biologics (WuXi Bio), listed in Hong Kong (stock code: 2269.HK), through its subsidiary in … Read the full press release